Black Diamond Therapeutics Inc (BDTX)
2.99
+0.10
(+3.46%)
USD |
NASDAQ |
Nov 04, 16:00
2.98
-0.01
(-0.33%)
After-Hours: 20:00
Black Diamond Therapeutics Total Liabilities (Quarterly): 38.96M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 38.96M |
| March 31, 2024 | 38.22M |
| December 31, 2023 | 41.83M |
| September 30, 2023 | 38.06M |
| June 30, 2023 | 37.68M |
| March 31, 2023 | 37.39M |
| December 31, 2022 | 40.56M |
| September 30, 2022 | 47.18M |
| June 30, 2022 | 46.46M |
| March 31, 2022 | 46.92M |
| December 31, 2021 | 51.78M |
| Date | Value |
|---|---|
| September 30, 2021 | 55.18M |
| June 30, 2021 | 36.86M |
| March 31, 2021 | 32.51M |
| December 31, 2020 | 21.91M |
| September 30, 2020 | 19.09M |
| June 30, 2020 | 6.325M |
| March 31, 2020 | 7.539M |
| December 31, 2019 | 205.45M |
| September 30, 2019 | 4.647M |
| December 31, 2018 | 67.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.325M
Minimum
Jun 2020
205.45M
Maximum
Dec 2019
44.73M
Average
38.22M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 8.116B |
| Ligand Pharmaceuticals Inc | 91.21M |
| Agios Pharmaceuticals Inc | 165.12M |
| ADMA Biologics Inc | 188.13M |
| AnaptysBio Inc | 417.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 149.99M |
| Shareholders Equity (Quarterly) | 111.02M |